We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.1B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$575M |
| 5 |
Cisco
CSCO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.73B |
| 3 |
UnitedHealth
UNH
|
+$856M |
| 4 |
Apple
AAPL
|
+$577M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.82% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
ArriVent BioPharma
AVBP
$1.4B
| $1.04M | ﹤0.01% |
47,663
+3,381
| +8% | +$70.2K |
|
2552
Vir Biotechnology
VIR
$1.48B
| $1.04M | ﹤0.01% |
205,480
-153,095
| -43% | -$821K |
|
2553
Mission Produce
AVO
$1.12B
| $1.03M | ﹤0.01% |
88,256
-20,226
| -19% | -$219K |
|
2554
Seneca Foods Class A
SENEA
$1.13B
| $1.03M | ﹤0.01% |
10,188
-5,451
| -35% | -$490K |
|
2555
American Public Education
APEI
$907M
| $1.03M | ﹤0.01% |
33,916
+5,184
| +18% | +$137K |
|
2556
Arcus Biosciences
RCUS
$3.5B
| $1.03M | ﹤0.01% |
126,838
-5,021
| -4% | -$42.9K |
|
|
FFWM
2557
DELISTED
First Foundation Inc
FFWM
| $1.03M | ﹤0.01% |
202,419
-22,320
| -10% | -$114K |
|
2558
Karat Packaging
KRT
$818M
| $1.03M | ﹤0.01% |
36,600
-316,827
| -90% | -$8.83M |
|
2559
Monro
MNRO
$529M
| $1.03M | ﹤0.01% |
69,101
-18,107
| -21% | -$261K |
|
2560
Genco Shipping & Trading
GNK
$1.09B
| $1.03M | ﹤0.01% |
78,462
-17,525
| -18% | -$232K |
|
|
EXK
2561
Endeavour Silver
EXK
$2.35B
| $1.02M | ﹤0.01% |
208,072
| – | – |
|
|
AGS
2562
DELISTED
PlayAGS
AGS
| $1.02M | ﹤0.01% |
81,569
-19,108
| -19% | -$233K |
|
2563
Clearfield
CLFD
$436M
| $1.02M | ﹤0.01% |
23,438
-10,745
| -31% | -$368K |
|
2564
OppFi
OPFI
$804M
| $1.02M | ﹤0.01% |
72,627
-43,413
| -37% | -$488K |
|
|
PKST
2565
DELISTED
Peakstone Realty Trust
PKST
| $1.01M | ﹤0.01% |
76,739
-15,766
| -17% | -$194K |
|
2566
Keros Therapeutics
KROS
$202M
| $1.01M | ﹤0.01% |
75,855
-3,871,600
| -98% | -$52.3M |
|
|
OLP
2567
One Liberty Properties
OLP
$551M
| $1.01M | ﹤0.01% |
42,353
-7,231
| -15% | -$177K |
|
|
DCH
2568
Dauch Corp
DCH
$1.32B
| $1M | ﹤0.01% |
245,821
-63,151
| -20% | -$254K |
|
|
BNT
2569
Brookfield Wealth Solutions
BNT
$11.7B
| $999K | ﹤0.01% |
24,296
-1,406,235
| -98% | -$52.1M |
|
2570
GSK
GSK
$104B
| $999K | ﹤0.01% |
26,015
-11,569
| -31% | -$442K |
|
2571
Relay Therapeutics
RLAY
$4.06B
| $998K | ﹤0.01% |
288,450
-31,945
| -10% | -$95K |
|
2572
Amylyx Pharmaceuticals
AMLX
$2.17B
| $997K | ﹤0.01% |
+155,536
| New | +$757K |
|
2573
Primis Financial Corp
FRST
$393M
| $996K | ﹤0.01% |
91,785
-8,567
| -9% | -$78.9K |
|
2574
Ramaco Resources Class A
METC
$664M
| $992K | ﹤0.01% |
75,523
+2,834
| +4% | +$27.1K |
|
|
XRN
2575
Chiron Real Estate Inc
XRN
$540M
| $986K | ﹤0.01% |
28,453
-6,186
| -18% | -$215K |
|
Similar funds
VFT
Nuveen's Q2 2025 Portfolio in Review
As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
- Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
- Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
- Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
- Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
- Nuveen opened 192 new positions and closed 199 in Q2 2025.
- Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.